Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter study

Clinical Immunology

Volumn 126, Issue 2, 2008, Pages 155-164

  Martire, Baldassarre ^a   Rondelli, Roberto ^b   Soresina, Annarosa ^c   Pignata, Claudio ^d   Broccoletti, Teresa ^d   Finocchi, Andrea ^e   Rossi, Paolo ^e   Gattorno, Marco ^f   Rabusin, Marco ^g   Azzari, Chiara ^h   Dellepiane, Rosa M ⁱ   Pietrogrande, Maria C ⁱ   Trizzino, Antonino ^j   Di Bartolomeo, Paolo ^k   Martino, Silvana ^l   Carpino, Luigi ^m   Cossu, Fausto ⁿ   Locatelli, Franco ^o   Maccario, Rita ^o   Pierani, Paolo ^p   Putti, Maria C ^q   Stabile, Achille ^r   Notarangelo, Luigi D ^c   Ugazio, Alberto G ^s   Plebani, Alessandro ^c   De Mattia, Domenico ^a   more..

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g UNIVERSITY OF TRIESTE   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j Ospedale dei Bambini G Di Cristina   (Italy)

^k Ospedale Civile di Pescara   (Italy)

^l UNIVERSITY OF TURIN   (Italy)

^m UOPediatria Ospedale Annunziata   (Italy)

ⁿ UNIVERSITY OF CAGLIARI   (Italy)

^o UNIVERSITY OF PAVIA   (Italy)

^p Ospedale Pediatrico G Salesi   (Italy)

^q UNIVERSITY OF PADOVA   (Italy)

^r CATHOLIC UNIVERSITY   (Italy)

^s BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

more..

Author keywords

Chronic Granulomatous Disease (CGD); Cotrimoxazole (CTX); Follow up; Infections; Interferon gamma (IFN ); Itraconazole (ITRA)

Indexed keywords

AMPHOTERICIN B; COTRIMOXAZOLE; FLUCONAZOLE; GAMMA INTERFERON; ITRACONAZOLE; VORICONAZOLE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; BRAIN ABSCESS; CAUSE OF DEATH; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DISEASE COURSE; DRUG EFFICACY; DRUG WITHDRAWAL; ENTERITIS; ENTEROCOLITIS; FATIGUE; FEMALE; FEVER; FOLLOW UP; FUNCTION TEST; GRANULOCYTE FUNCTION; HEADACHE; HUMAN; INCIDENCE; LIVER ABSCESS; LONG TERM CARE; LUNG ABSCESS; LYMPHADENITIS; MALE; MULTICENTER STUDY; MYALGIA; OSTEOMYELITIS; OTITIS; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RASH; SEPTICEMIA; SINGLE DRUG DOSE; SINUSITIS; SKIN ABSCESS; SURVIVAL RATE; TREATMENT DURATION;

ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INFANT; INTERFERON TYPE II; ITALY; ITRACONAZOLE; KAPLAN-MEIERS ESTIMATE; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 37849008955     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.09.008     Document Type: Article

References (39)

1. Segal B.H., Leto T.L., Gallin J.L., Malech H.L., and Holland S.M. Genetic biochemical, and clinical features of chronic granulomatous disease. Medicine 79 (2000) 170-200
2. Dinauer M.C., and Orkin S.H. Chronic granulomatous disease. Annu. Rev. Med. 43 (1992) 117-124
3. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1475
4. Curnutte J.T. Chronic granulomatous disease: the solving of a clinical riddle at the molecular level. Clin. Immunol. Immunopathol. 67 (1993) 12-15
5. Dinauer M.C., Pierce E.A., Bruns G.A., Curnutte J.T., and Orkin S.H. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J. Clin. Invest. 86 (1990) 1729-1737
6. Francke U., Hsieh C.L., Foellmer B.E., Lomax K.J., Malech H.L., and Leto T.L. Genes for two autosomal recessive forms of chronic granulomatous disease assigned to 1q25 (NCF2) and 7q11.23 (NCF1). Am. J. Hum. Genet. 47 (1990) 483-492
7. Roos D., de Boer M., de Klein A., Bolscher B.G., and Weening R.S. Chronic granulomatous disease: mutations in cytochrome b558. Immunodeficiency 4 (1993) 289-301
8. Weening R.S., Kabel P., Pijman P., and Roos D. Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J. Pediatr. 103 (1983) 127-130
9. Margolis D.M., Melnick D.A., Alling D.W., and Gallin J.I. Trimethoprimsulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J. Infect. Dis. 162 (1990) 723-726
10. Petropoulou T., Liese J., Tintelnot K., Gahr M., and Belohradsky B.H. Long-term treatment of patients with itraconazole for the prevention of Aspergillus infections in patients with chronic granulomatous disease (CGD). Langzeitbehandlung mit Itraconazol zur Prophylaxe von Aspergillus-Infektionen bei Patienten mit chronischer Granulomatose (CGD). Mycoses 37 Suppl. 2 (1994) 64-69
11. Mouy R., Veber F., Blanche S., Donadieu J., Brauner R., Levron J.C., Griscelli C., and Fisher A. Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J. Pediatr. 125 (1994) 998-1003
12. The International chronic granulomatous disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in Chronic Granulomatous Disease. N. Engl. J. Med. 324 (1991) 509-516
13. Weening R.S., Leitz G.J., and Seger R.A. Recombinant human interferon-gamma in patients with chronic granulomatous disease - European follow up study. Eur. J. Pediatr. 154 (1995) 295-298
14. Bemiller L.S., Roberts D.H., Starko K.M., and Curnutte J.T. Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease. Blood Cells Mol. Diseases 21 (1995) 239-247
15. Marciano B.E., Wesley R., DeCarlo E.S., Anderson V.L., Barnhart L.A., Dornell D., Malech H.L., Gallin J.I., and Holland S.M. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin. Infect. Diseases 39 (2004) 692-699
16. Hasui M. Chronic granulomatous disease in Japan: incidence and natural history. The study group of Phagocyte Disorders of Japan. Pediatr. Int. 41 (1999) 589-593
17. Ahlin A., De Boer M., Roos D., Lensen J., Smith C.L., Sundin U., Rabbani H., Palmblad J., and Elinder G. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 84 (1995) 1386-1394
18. Winkelstein J.A., Marino M.C., Johnston R.B., Boyle J., Curnutte J., Gallin Jl J.I., Malech H.L., Holland S.M., Ochs H., Quie P., Buckey R.H., Foster C.B., Chanock S.J., and Dickler H. Chronic granulomatous disease. Report on a national registry of 368 patient. Medicine (Baltimore) 79 (2000) 155-169
19. Liese J., Kloos S., Jendrossek V., Petropoulou T., Wintergerst U., Notheis G., Gahr M., and Belohradsky B.H. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J. Pediatr. 137 (2000) 687-693
20. Mouy R., Fischer A., Vilmer E., Seger R., and Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J. Pediatr. 14 (1989) 555-560
21. Guide S.V., Stock F., Gill V.J., Anderson V.L., Malech H.L., Gallin J.I., and Holland S.M. Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J. Infect. Dis. 187 (2003) 845-853
22. Cale C.M., Jones A.M., and Goldblatt D. Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin. Exp. Immunol. 120 (2000) 351-355
23. Mouy R., Seger R., Bourquin J.P., Veber F., Blanche S., Griscelli C., and Fisher A. Interferon gamma for chronic granulomatous disease. N. Engl. J. Med. 325 (1991) 1516-1517
24. Goldblatt D., and Thrasher A.J. Chronic granulomatous disease. Clin. Exp. Immunol. 122 (2000) 1-9
25. Johnstonn Jr. R.B., and Baehner R.L. Chronic granulomatous disease: correlation between pathogenesis and clinical findings. Pediatrics 48 (1971) 730-739
26. Lazarus G.M., and Neu H.C. Agents responsible for infection in chronic granulomatous disease of childhood. J. Pediatr. 86 (1975) 415-417
27. Jabado N., Casanova J.L., Haddad E., Dulieu F., Fournet J.C., Dupont B., Fisher A., Hennequin C., and Blanche S. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin. Infect. Dis. 27 (1998) 1437-1441
28. Roilides E., Sigler L., Bibashi E., Katsifa H., Flaris N., and Panteliadis C. Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J. Clin. Microbiol. 37 (1999) 18-25
29. Dorman S.E., Guide S.V., Conville P.S., DeCarlo E.S., Malech H.L., Gallin J.I., Witebsky F.G., and Holland S.M. Nocardia infection in chronic granulomatous disease. Clin. Infect. Dis. 35 (2002) 390-394
30. Walther M.M., Malech H., Berman A., Choyke P., Venzon D.J., Linehan W.M., and Gallin J.I. The urological manifestations of chronic granulomatous disease. J. Urol. 47 (1992) 1314-1318
31. Kim S.J., Kim J.G., and Yu Y.S. Chorioretinal lesions in patients with chronic granulomatous disease. Retina 23 (2003) 360-365
32. Badolato R., Notarangelo L.D., Plebani A., and Roos D. Development of systemic lupus erythematosus in a young child affected with chronic granulomatous disease following withdrawal of treatment with interferon-γ. Rheumatology 42 (2003) 804-805
33. Levine S., Smith V.V., Malone M., and Sebire N.J. Histopathological features of chronic granulomatous disease (CGD) in childhood. Histopathology 47 (2005) 508-516
34. Liese J.G., Jendrossek V., Jansson A., Petropoulou T., Kloos S., Gahr M., and Belohradsky B.H. Chronic granulomatous disease in adults. Lancet 347 (1996) 220-223
35. Foster C.B., Lehrnbecher T., Mol F., Steinberg S.M., Venzon D.J., Walsh T.J., Noack D., Rae J., Winkelstein J.A., Curnutte J.T., and Chanock S.J. Host defence molecule polymorphism influence the risk for immune-mediated complications in chronic granulomatous disease. J. Clin. Invest. 102 (1998) 2146-2155
36. Marciano B.E., Rosenzweig S.D., Kleiner D.E., Anderson V.L., Darnell D.N., Anaya-O'Brien S., Hilligoss D.M., Malech H.L., Gallin J.I., and Holland S.M. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114 (2004) 462-468
37. Schappi M.G., Klein N.J., Lindley K.J., Rampling D., Smith V.V., Goldblatt D., and Milla P.J. The nature of colitis in chronic granulomatous disease. J. Pediatr. Gastroenterol. Nutr. 36 (2003) 623-631
38. Brown J.R., Goldblatt D., Buddle J., Morton L., and Thrasher A.J. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease. J. Leukoc. Biol. 73 (2003) 591-599
39. Finn A., Hadzic N., Morgan G., Strobel S., and Levinsky R.J. Prognosis of chronic granulomatous disease. Arch. Dis. Child. 65 (1990) 942-945